Product NDC: | 44911-0019 |
Proprietary Name: | Adrenapar |
Non Proprietary Name: | Aralia Quinoquefolia, Avena Sativa, Glandula Suparenalis Suis, Arsenicum Iodatum, Ignatia Amara, Lycopodium Clavatum, Nux Vomica |
Active Ingredient(s): | 3; 12; 3; 12; 12; 12; 12; 12; 6; 12 [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL & nbsp; Aralia Quinoquefolia, Avena Sativa, Glandula Suparenalis Suis, Arsenicum Iodatum, Ignatia Amara, Lycopodium Clavatum, Nux Vomica |
Administration Route(s): | ORAL |
Dosage Form(s): | LIQUID |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 44911-0019 |
Labeler Name: | Energique, Inc. |
Product Type: | HUMAN OTC DRUG |
FDA Application Number: | |
Marketing Category: | UNAPPROVED HOMEOPATHIC |
Start Marketing Date: | 20120820 |
Package NDC: | 44911-0019-1 |
Package Description: | 30 mL in 1 BOTTLE, DROPPER (44911-0019-1) |
NDC Code | 44911-0019-1 |
Proprietary Name | Adrenapar |
Package Description | 30 mL in 1 BOTTLE, DROPPER (44911-0019-1) |
Product NDC | 44911-0019 |
Product Type Name | HUMAN OTC DRUG |
Non Proprietary Name | Aralia Quinoquefolia, Avena Sativa, Glandula Suparenalis Suis, Arsenicum Iodatum, Ignatia Amara, Lycopodium Clavatum, Nux Vomica |
Dosage Form Name | LIQUID |
Route Name | ORAL |
Start Marketing Date | 20120820 |
Marketing Category Name | UNAPPROVED HOMEOPATHIC |
Labeler Name | Energique, Inc. |
Substance Name | AMERICAN GINSENG; ARSENIC TRIIODIDE; AVENA SATIVA FLOWERING TOP; LYCOPODIUM CLAVATUM SPORE; PHOSPHORIC ACID; PHOSPHORUS; STRYCHNOS IGNATII SEED; STRYCHNOS NUX-VOMICA SEED; SUS SCROFA ADRENAL GLAND; ZINC |
Strength Number | 3; 12; 3; 12; 12; 12; 12; 12; 6; 12 |
Strength Unit | [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL |
Pharmaceutical Classes |